secwatch.observer — SEC 8-K summary
======================================

Issuer:     NORTHWEST BIOTHERAPEUTICS INC (NWBO)
CIK:        0001072379
Form:       8-K
Filed at:   2024-11-01T23:59:59+00:00
Accession:  0001104659-24-113553
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03
LLM model:  deepseek-v4-flash:cloud@v2

Northwest Biotherapeutics enters $5M convertible note with 11% interest, 24-month maturity
--------------------------------------------------------------------------------

- Company entered $5,000,000 convertible note with an unrelated shareholder on Oct 31, 2024.
- Note matures in 24 months with no payments due until maturity; interest at 11% per annum.
- Holder can convert into common stock at $0.30/share or non-dilutive financial instrument priced at $50,000.
- Proceeds will be used for ongoing business operations; customary default provisions apply.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1072379/000110465924113553/0001104659-24-113553-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1072379/000110465924113553/tm2420750d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-113553

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer